CD8A and Epstein-Barr virus infection: While CD8+ T cells rapidly expanded in the first five weeks with kinetics similar to IM [50] during high dose EBV infection, low dose EBV infection (103 infectious particles) led to a gradual and more moderate increase in CD8+ T cell expansion, which plateaued at six to eight weeks after infection and seemed to decline after eleven weeks (Fig 8A).